Inspire Medical Systems, Inc. Interest Expense
Inspire Medical Systems, Inc. (INSP) reported Interest Expense of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-02-09
- Inspire Medical Systems, Inc. interest expense for the quarter ending 2023-12-31 was $0.00.
- Inspire Medical Systems, Inc. interest expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. interest expense for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. interest expense for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. interest expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Inspire Medical Systems, Inc. interest expense for fiscal 2022 was $1.68M, a 21.19% decline from fiscal 2021.
- Inspire Medical Systems, Inc. interest expense for fiscal 2021 was $2.13M, a 0.52% increase from fiscal 2020.
- Inspire Medical Systems, Inc. interest expense for fiscal 2020 was $2.12M, a 0.09% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-09 | $0.00 10-K · filed 2024-02-09 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-02-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-01 | $0.00 10-Q · filed 2023-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-02-09 | $656.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 | $0.00 derived: sum of 2 quarters · filed 2024-02-09 | $656.00K derived: sum of 3 quarters · filed 2024-02-09 | $1.15M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $656.00K derived: sum of 2 quarters · filed 2024-02-09 | $1.15M derived: sum of 3 quarters · filed 2024-02-09 | $1.68M 10-K · filed 2024-02-09 |
| 2022-09-30 | $656.00K 10-Q · filed 2023-11-07 | $1.15M derived: sum of 2 quarters · filed 2023-11-07 | $1.68M 10-Q · filed 2023-11-07 | $2.21M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $494.00K 10-Q · filed 2023-08-01 | $1.02M 10-Q · filed 2023-08-01 | $1.56M derived: sum of 3 quarters · filed 2024-02-09 | $2.10M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $527.00K 10-Q · filed 2023-05-02 | $1.06M derived: sum of 2 quarters · filed 2024-02-09 | $1.60M derived: sum of 3 quarters · filed 2024-02-09 | $2.13M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.07M derived: sum of 2 quarters · filed 2024-02-09 | $1.60M derived: sum of 3 quarters · filed 2024-02-09 | $2.13M 10-K · filed 2024-02-09 |
| 2021-09-30 | $537.00K 10-Q · filed 2022-11-01 | $1.07M derived: sum of 2 quarters · filed 2022-11-01 | $1.59M 10-Q · filed 2022-11-01 | $2.12M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $530.00K 10-Q · filed 2022-08-02 | $1.05M 10-Q · filed 2022-08-02 | $1.59M derived: sum of 3 quarters · filed 2023-02-10 | $2.12M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $523.00K 10-Q · filed 2022-05-03 | $1.06M derived: sum of 2 quarters · filed 2023-02-10 | $1.59M derived: sum of 3 quarters · filed 2023-02-10 | $2.12M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.07M derived: sum of 2 quarters · filed 2023-02-10 | $1.59M derived: sum of 3 quarters · filed 2023-02-10 | $2.12M 10-K · filed 2023-02-10 |
| 2020-09-30 | $533.00K 10-Q · filed 2021-11-02 | $1.06M derived: sum of 2 quarters · filed 2021-11-02 | $1.58M 10-Q · filed 2021-11-02 | $2.11M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $526.00K 10-Q · filed 2021-08-03 | $1.05M 10-Q · filed 2021-08-03 | $1.58M derived: sum of 3 quarters · filed 2022-02-15 | $2.11M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $525.00K 10-Q · filed 2021-05-04 | $1.05M derived: sum of 2 quarters · filed 2022-02-15 | $1.58M derived: sum of 3 quarters · filed 2022-02-15 | $2.11M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $530.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.06M derived: sum of 2 quarters · filed 2022-02-15 | $1.58M derived: sum of 3 quarters · filed 2022-02-15 | $2.12M 10-K · filed 2022-02-15 |
| 2019-09-30 | $529.00K 10-Q · filed 2020-11-02 | $1.05M derived: sum of 2 quarters · filed 2020-11-02 | $1.59M 10-Q · filed 2020-11-02 | $2.28M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $523.00K 10-Q · filed 2020-08-04 | $1.06M 10-Q · filed 2020-08-04 | $1.75M derived: sum of 3 quarters · filed 2021-02-24 | $2.43M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $537.00K 10-Q · filed 2020-05-05 | $1.23M derived: sum of 2 quarters · filed 2021-02-24 | $1.91M derived: sum of 3 quarters · filed 2021-02-24 | $2.46M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $689.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.37M derived: sum of 2 quarters · filed 2021-02-24 | $1.92M derived: sum of 3 quarters · filed 2021-02-24 | $3.30M 10-K · filed 2021-02-24 |
| 2018-09-30 | $680.00K 10-Q · filed 2019-11-05 | $1.23M derived: sum of 2 quarters · filed 2019-11-05 | $2.62M 10-Q · filed 2019-11-05 | $3.14M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $550.00K 10-Q · filed 2019-08-06 | $1.94M 10-Q · filed 2019-08-06 | $2.46M derived: sum of 3 quarters · filed 2020-02-25 | $2.89M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $1.39M 10-Q · filed 2019-05-07 | $1.91M derived: sum of 2 quarters · filed 2020-02-25 | $2.34M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-31 | $529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $957.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.75M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $428.00K 10-Q · filed 2018-11-06 | $1.22M 10-Q · filed 2018-11-06 | ||
| 2016-12-31 | $1.30M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |